Neoproteomics Inc is categorized under Chemical Laboratory, Except Testing in Cleveland, OH and active since 2001.
Neoproteomics Inc was established in 2001, and today employs 1 to 4, earning Unknown per year. This is a Chemical Laboratory, Except Testing business, which does work in the B2B market, and is classified as a Chemical Laboratory, Except Testing, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact John Schenkel at the company’s single location by writing to 11000 Cedar Avenue # 100, Cleveland, Ohio OH 44106 or by phoning (216) 410-5181. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Neoproteomics Inc |
| Contact Person: | John Schenkel |
| Address: | 11000 Cedar Avenue # 100, Cleveland, Ohio 44106 |
| Phone Number: | (216) 410-5181 |
| Website Address: | neoproteomics.net |
| Annual Revenue (USD): | Unknown |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Chemical Laboratory, Except Testing |
| SIC Code: | 8731 |
| NAICS Code: | 5419100 |
| Share This Business: |
Neoproteomics Inc was started in 2001 to provide professional Chemical Laboratory, Except Testing under the SIC code 8731 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact John Schenkel for inquiries that concern Neoproteomics Inc by calling the company number (216) 410-5181, as your correspondence is most welcome. Additionally, the physical location of the single location of Neoproteomics Inc can be found at the coordinates 41.49973,-81.6079 as well as the street address 11000 Cedar Avenue # 100 in Cleveland, Ohio 44106.
For its online presence, you may visit Neoproteomics Inc’s website at neoproteomics.net and engage with its social media outlets through on Twitter and on Facebook.